SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-177164
Filing Date
2021-05-28
Accepted
2021-05-28 17:01:07
Documents
12
Period of Report
2021-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d160590d8k.htm   iXBRL 8-K 51814
  Complete submission text file 0001193125-21-177164.txt   177420

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210527.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210527_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210527_pre.xml EX-101.PRE 11424
5 EXTRACTED XBRL INSTANCE DOCUMENT d160590d8k_htm.xml XML 3353
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 21981390
SIC: 2834 Pharmaceutical Preparations